In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed the day trading at $32.18 down -5.38% from the previous closing price of $34.01. In other words, the price has decreased by -$5.38 from its previous closing price. On the day, 0.99 million shares were traded. TNXP stock price reached its highest trading level at $34.0 during the session, while it also had its lowest trading level at $32.0301.
Ratios:
For a better understanding of TNXP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.22 and its Current Ratio is at 7.53. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 21 ’25 when Taylor Carolyn E. bought 418 shares for $36.03 per share. The transaction valued at 15,061 led to the insider holds 418 shares of the business.
Treco James bought 250 shares of TNXP for $9,000 on Aug 20 ’25. The Director now owns 250 shares after completing the transaction at $36.00 per share. On May 15 ’25, another insider, LEDERMAN SETH, who serves as the Chief Executive Officer of the company, bought 4,000 shares for $21.55 each. As a result, the insider paid 86,200 and bolstered with 4,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 282086656 and an Enterprise Value of 157247536. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.70 while its Price-to-Book (P/B) ratio in mrq is 1.45. Its current Enterprise Value per Revenue stands at 15.995 whereas that against EBITDA is -1.968.
Stock Price History:
The Beta on a monthly basis for TNXP is 1.88, which has changed by 0.23769236 over the last 52 weeks, in comparison to a change of 0.1590569 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $130.00, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is -22.20%, while the 200-Day Moving Average is calculated to be 16.69%.
Shares Statistics:
Over the past 3-months, TNXP traded about 1.40M shares per day on average, while over the past 10 days, TNXP traded about 2539650 shares per day. A total of 8.77M shares are outstanding, with a floating share count of 8.76M. Insiders hold about 0.08% of the company’s shares, while institutions hold 16.09% stake in the company. Shares short for TNXP as of 1755216000 were 1347517 with a Short Ratio of 0.96, compared to 1752537600 on 1188503. Therefore, it implies a Short% of Shares Outstanding of 1347517 and a Short% of Float of 15.370000000000001.
Earnings Estimates
The dynamic stock of Tonix Pharmaceuticals Holding Corp (TNXP) is currently being evaluated by a team of 1.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$3.05, with high estimates of -$3.05 and low estimates of -$3.05.
Analysts are recommending an EPS of between -$10.3 and -$10.3 for the fiscal current year, implying an average EPS of -$10.3. EPS for the following year is -$4.5, with 1.0 analysts recommending between -$4.5 and -$4.5.
Revenue Estimates
1 analysts predict $2.1M in revenue for the current quarter. It ranges from a high estimate of $2.1M to a low estimate of $2.1M. As of the current estimate, Tonix Pharmaceuticals Holding Corp’s year-ago sales were $2.82MFor the next quarter, 1 analysts are estimating revenue of $2.2M. There is a high estimate of $2.2M for the next quarter, whereas the lowest estimate is $2.2M.
A total of 1 analysts have provided revenue estimates for TNXP’s current fiscal year. The highest revenue estimate was $8.7M, while the lowest revenue estimate was $8.7M, resulting in an average revenue estimate of $8.7M. In the same quarter a year ago, actual revenue was $10.09MBased on 3 analysts’ estimates, the company’s revenue will be $94.17M in the next fiscal year. The high estimate is $203.5M and the low estimate is $31.3M.
